UK-US deal is good news for NHS patients and will help to support UK life sciences competitiveness, says ABPI
Industry hopes the new trade agreement will allow more innovative medicines to reach a greater number of NHS patients and will be a positive step in supporting the UK life sciences industry.
Read the full articleYou might also wanna read
NHS Fast-tracks Life-changing Medicines in Landmark UK-US Access Overhaul
A new series of NHS pilot schemes could give patients access to innovative medicines months earlier while supporting investment in the UK's
Analysis: UK-US trade deal could lead to 229,000 excess NHS deaths and £45bn in diverted funds
Analysis reveals extent of impact on NHS of placating Donald Trump over price of British medicine exports
theguardian.com·9d agoAnalysis: UK-US trade deal could lead to 229,000 excess NHS deaths and £45bn in diverted funds
Analysis reveals extent of impact on NHS of placating Donald Trump over price of British medicine exports
theguardian.com·9d ago
Analysis: US-UK trade deal could force NHS to divert billions to medicines, critics warn
The NHS will divert billions of pounds from essential services to pay for new medicines under the terms of the US-UK trade deal agreed last
theguardian.com·7d agoAnalysis: UK-US trade deal could force NHS to divert £45bn, causing 229,000 excess deaths in England
Analysis reveals extent of impact on NHS of placating Donald Trump over price of British medicine exports
theguardian.com·8d ago
A dangerous deal. An interesting story is gaining momentum in Britain around the British healthcare system (NHS) and the drug deal that the government concluded with the United States under Donald Trump last December
A dangerous dealAn interesting story is gaining momentum in Britain around the British healthcare system (NHS) and the drug deal that the go
Analysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health
Samuel Cross, Karl Claxton, and Andrew Hill argue that diversion of billions of NHS funding to pay more for new drugs under the UK-US trade
bmj.com·8d agoAnalysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health
Samuel Cross, Karl Claxton, and Andrew Hill argue that diversion of billions of NHS funding to pay more for new drugs under the UK-US trade
bmj.com·8d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.